← Leaderboards
Jasti S Rao
University Of Texas Md Anderson Can Ctr
$18,364,597
Attributed
$18,364,597
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2005–12$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$18,364,597 · 13
By mechanism
R01$18,269,907 · 12
S10$94,690 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisGliomaCell LineBehaviorMigrationTumor GrowthIn VivoIn VitroAdhesionsTumorAngiogenesisCancer CellMolecularMalignant NeoplasmsCerebrumGrowthModalityIntracranial NeoplasmsCell GrowthRecurrencePeptide HydrolasesBrain NeoplasmsIn Vivo ModelCells
Grant awards (64)
Combination therapy to inhibit neuroblastoma growth$355,503
R01 · FY2012 · CA · contact PI
Regression of meningioma tumor growth by combination therapy$336,569
R01 · FY2012 · NS · contact PI
Combination therapy to inhibit glioma growth by Ad MMP2 and radiation$336,569
R01 · FY2012 · NS · contact PI
Cath B and uPAR si RNA constructs regressed glioma growth$330,460
R01 · FY2012 · CA · contact PI
Inhibition of matrix proteases to sensitize medulloblastoma cells to radiation$316,002
R01 · FY2012 · CA · contact PI
Combination therapy to inhibit neuroblastoma growth$355,503
R01 · FY2011 · CA · contact PI
Regression of meningioma tumor growth by combination therapy$336,569
R01 · FY2011 · NS · contact PI
Combination therapy to inhibit glioma growth by Ad MMP2 and radiation$336,569
R01 · FY2011 · NS · contact PI
Inhibition of glioma tumor growth by antisense MMP-9$332,281
R01 · FY2011 · NS · contact PI
Cath B and uPAR si RNA constructs regressed glioma growth$330,460
R01 · FY2011 · CA · contact PI
Inhibition of matrix proteases to sensitize medulloblastoma cells to radiation$316,002
R01 · FY2011 · CA · contact PI
Regression of meningioma tumor growth by combination therapy$340,004
R01 · FY2010 · NS · contact PI
Combination therapy to inhibit glioma growth by Ad MMP2 and radiation$340,004
R01 · FY2010 · NS · contact PI
Inhibition of glioma tumor growth by antisense MMP-9$335,673
R01 · FY2010 · NS · contact PI
Inhibition of matrix proteases to sensitize medulloblastoma cells to radiation$325,775
R01 · FY2010 · CA · contact PI
Growth inhibition of brain tumors by cord blood stem cells$254,353
R01 · FY2010 · NS · contact PI
Combination therapy to inhibit neuroblastoma growth$162,888
R01 · FY2010 · CA · contact PI
Cath B and uPAR si RNA constructs regressed glioma growth$151,414
R01 · FY2010 · CA · contact PI
GE Healthcare Fast Protein Liquid Chromatography FPLC product number 13470501.$94,690
S10 · FY2010 · RR · contact PI
Growth inhibition of brain tumors by cord blood stem cells$399,179
R01 · FY2009 · NS · contact PI
Regression of meningioma tumor growth by combination therapy$343,438
R01 · FY2009 · NS · contact PI
Combination therapy to inhibit glioma growth by Ad MMP2 and radiation$343,438
R01 · FY2009 · NS · contact PI
Inhibition of glioma tumor growth by antisense MMP-9$339,063
R01 · FY2009 · NS · contact PI
Inhibition of matrix proteases to sensitize medulloblastoma cells to radiation$325,775
R01 · FY2009 · CA · contact PI
Cath B and muPAR siRNA constructs regressed glioma growth$290,262
R01 · FY2009 · CA · contact PI
Role of uPA and uPAR in Human Glioma Invasiveness$231,475
R01 · FY2009 · CA · contact PI
Growth inhibition of brain tumors by cord blood stem cells$390,181
R01 · FY2008 · NS · contact PI
Regression of meningioma tumor growth by combination therapy$343,438
R01 · FY2008 · NS · contact PI
Inhibition of glioma tumor growth by antisense MMP-9$339,063
R01 · FY2008 · NS · contact PI
Cath B and muPAR siRNA constructs regressed glioma growth$290,262
R01 · FY2008 · CA · contact PI
Role of uPA and uPAR in Human Glioma Invasiveness$231,475
R01 · FY2008 · CA · contact PI
Growth inhibition of brain tumors by cord blood stem cells$392,880
R01 · FY2007 · NS · contact PI
Inhibition of glioma tumor growth by antisense MMP-9$339,063
R01 · FY2007 · NS · contact PI
Role of TFPI-2 in human gliomas invasiveness$295,955
R01 · FY2007 · CA · contact PI
Cath B and muPAR siRNA constructs regressed glioma growth$290,262
R01 · FY2007 · CA · contact PI
Suppression of glioma invasion by a bicistronic constuct$263,072
R01 · FY2007 · CA · contact PI
Role of uPA and uPAR in Human Glioma Invasiveness$231,475
R01 · FY2007 · CA · contact PI
Growth inhibition of brain tumors by cord blood stem cells$395,622
R01 · FY2006 · NS · contact PI
Role of TFPI-2 in human gliomas invasiveness$304,794
R01 · FY2006 · CA · contact PI
Cath B and muPAR siRNA constructs regressed glioma growth$298,931
R01 · FY2006 · CA · contact PI
Suppression of glioma invasion by a bicistronic constuct$270,929
R01 · FY2006 · CA · contact PI
Role of uPA and uPAR in Human Glioma Invasiveness$238,388
R01 · FY2006 · CA · contact PI
Role of TFPI-2 in human gliomas invasiveness$312,130
R01 · FY2005 · CA
Cath B and muPAR siRNA constructs regressed glioma growth$306,125
R01 · FY2005 · CA
Suppression of glioma invasion by a bicistronic constuct$277,449
R01 · FY2005 · CA
Inhibition of glioma tumor growth by antisense MMP-9$259,134
R01 · FY2005 · NS
Role of uPA and uPAR in Human Glioma Invasiveness$244,125
R01 · FY2005 · CA
Role of TFPI-2 in human gliomas invasiveness$312,130
R01 · FY2004 · CA
Suppression of glioma invasion by a bicistronic constuct$277,449
R01 · FY2004 · CA
Inhibition of glioma tumor growth by antisense MMP-9$259,134
R01 · FY2004 · NS
EFFECT OF SERINE PROTEASES BY RADIATION IN CNS INJURY$245,495
R01 · FY2004 · CA
Role of uPA and uPAR in Human Glioma Invasiveness$226,401
R01 · FY2004 · CA
Role of TFPI-2 in human gliomas invasiveness$312,130
R01 · FY2003 · CA
Suppression of glioma invasion by a bicistronic constuct$277,449
R01 · FY2003 · CA
Inhibition of glioma tumor growth by antisense MMP-9$259,134
R01 · FY2003 · NS
EFFECT OF SERINE PROTEASES BY RADIATION IN CNS INJURY$245,495
R01 · FY2003 · CA
Role of uPA and uPAR in Human Glioma Invasiveness$226,401
R01 · FY2003 · CA
EFFECT OF SERINE PROTEASES BY RADIATION IN CNS INJURY$245,495
R01 · FY2002 · CA
Role of uPA and uPAR in Human Glioma Invasiveness$226,401
R01 · FY2002 · CA
Role of uPA and uPAR in Human Glioma Invasiveness$226,401
R01 · FY2001 · CA
CATHEPSIN B AND HUMAN GLIOMA INVASIVENESS$261,489
R01 · FY2000 · CA
EFFECT OF SERINE PROTEASES BY RADIATION IN CNS INJURY$245,495
R01 · FY2000 · CA
REGULATION OF UPA AND UPAR IN HUMAN GLIOMA INVASIVENESS$223,691
R01 · FY2000 · CA
CATHEPSIN B AND HUMAN GLIOMA INVASIVENESS$19,736
R01 · FY2000 · CA